Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study to Assess the Efficacy of Cannabigerol in Patients with Active Rheumatoid Arthritis.

NCT06513507 is registered in ClinicalTrials.gov with Raphael Pharma as lead sponsor.

NCT NCT06513507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06513507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study to Assess the Efficacy of Cannabigerol in Patients with Active Rheumatoid Arthritis.
Lead sponsor
Raphael Pharma
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 3, 2024
Completion date
December 31, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory disease, rheumatoid arthritis